Browsing Tag
Mark Cross
1 post
Xero (ASX: XRO) climbs into FY2026 result as Melio integration becomes the central thesis test
Xero spent US$2.5bn on Melio. Shares are down 57% from the highs. The May 14 result is when bulls and bears find out who was right.